Formoterol Fumarate Dihydrate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

35 API Suppliers, 15 USDMF, 14 CEP/COS, 4 JDMF, 8 EU WC, 12 KDMF, 21 NDC API, 26 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

24 Drugs in Development

24 Drugs in Development

INTERMEDIATES

11 Intermediates Suppliers

11 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

319 FDF Dossiers, 21 FDA Orange Book, 243 Europe, 8 Canada, 3 Australia, 11 South Africa, 33 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

POWDER;INHALATION - 0.012MG/INH **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, POWDER, METERED;INHALATION - 0.4MG/INH;0.012MG/INH, AEROSOL, METERED;INHALATION - 0.08MG/INH;0.0045MG/INH, AEROSOL, METERED;INHALATION - 0.16MG/INH;0.0045MG/INH, AEROSOL, METERED;INHALATION - 0.005MG/INH;0.05MG/INH, AEROSOL, METERED;INHALATION - 0.005MG/INH;0.1MG/INH, AEROSOL, METERED;INHALATION - 0.005MG/INH;0.2MG/INH

RELATED EXCIPIENT COMPANIES

2 Nanjing Well Pharmaceutical, 5 Actylis, 2 BASF, 1 Clariant, 1 Finar, 3 Kerry, 1 Microlex e.U, 1 Nippon Fine Chemical, 1 Roquette

EXCIPIENTS BY APPLICATIONS

5 Parenteral, 3 Topical, 3 Controlled & Modified Release, 3 Co-Processed Excipients, 2 Fillers, Diluents & Binders, 2 Granulation, 2 Direct Compression, 2 Emulsifying Agents, 1 Coating Systems & Additives, 1 Thickeners and Stabilizers, 1 Solubilizers, 1 Dry Powder Inhalation, 1 Film Formers & Plasticizers, 1 Lubricants & Glidants, 1 Surfactant & Foaming Agents